Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Stearoyl-CoA desaturase inhibitors for treatment of acne claimed by GlaxoSmithKline

Jan. 19, 2010

PhotoMedex and Galderma Laboratories sign copromotion agreement for Metvixia for AK

Jan. 13, 2010

FDA grants marketing approval to Hi-Tech Pharmacal's Tropazone dermatitis treatment

Jan. 12, 2010

InNexus Biotechnology develops new skin-permeating psoriasis product

Jan. 12, 2010

Phase II trial of AZX-100 for dermal scarring completes enrollment

Jan. 7, 2010

EXC-001 enters phase II trials for improving surgery-related scar appearance

Jan. 7, 2010

Eli Lilly moves LY-2525623 into phase II for psoriasis

Jan. 4, 2010

LEO-29102 enters phase II study for atopic dermatitis

Dec. 31, 2009

Lactobacillus rhamnosus CGMCC 1.3724 may prevent atopic dermatitis onset

Dec. 28, 2009

Leo Pharma reports results from phase III clinical trials of PEP-005

Dec. 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....